Literature DB >> 28056753

Role of ncRNAs in Development, Diagnosis and Treatment of Human Cancer.

Francisco E Nicolas1.   

Abstract

BACKGROUND: Since the first reports of microRNAs and the advent of new sequencing technologies, a whole new world of regulatory non-conding RNAs (ncRNAs) has revolutionized our knowledge of the RNA dimension. Thousands of functional non-coding transcripts have been identified and grouped into new classes of ncRNAs attending to their origin and function. Despite the fact that we have just started to study ncRNAs, it is now clear that these new regulatory actors play an important role in most of the regulated biological processes and in almost all species.
OBJECTIVE: An overview of the state of the art in ncRNAs and the development, diagnosis and treatment of human cancer.
METHOD: NcRNAs are deeply involved in the regulation of key genes that are associated with human cancer, representing a promising field for new therapies. This review summarizes the origin, structure and function of the most relevant new classes of ncRNAs, playing special attention to the studies that have related these new regulatory factors with the development of human cancer.
RESULTS: From a thorough literature review on scientific publications and patented applications, this review presents recent advances related to ncRNAs and human cancer. In addition, a selection of patents that use ncRNAs to develop new methodologies for the diagnosis and treatment of cancer is included and described in each class of ncRNAs.
CONCLUSION: The regulatory potential of ncRNAs opens a new research field that will uncover new and promising aspects in the study of human cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer; lincRNA; lncRNA; miRNA; ncRNAs; piRNAs; snoRNA; tiRNAs

Mesh:

Substances:

Year:  2017        PMID: 28056753     DOI: 10.2174/1574892812666170105113415

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  14 in total

Review 1.  Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy.

Authors:  Yiye Shao; Yinghui Chen
Journal:  Front Mol Neurosci       Date:  2017-08-10       Impact factor: 5.639

Review 2.  Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome.

Authors:  Ge Huang; He Zhu; Shuying Wu; Manhua Cui; Tianmin Xu
Journal:  Front Genet       Date:  2019-05-22       Impact factor: 4.599

3.  Circular RNA Expression Alteration and Bioinformatics Analysis in Rats After Traumatic Spinal Cord Injury.

Authors:  Chuan Qin; Chang-Bin Liu; De-Gang Yang; Feng Gao; Xin Zhang; Chao Zhang; Liang-Jie Du; Ming-Liang Yang; Jian-Jun Li
Journal:  Front Mol Neurosci       Date:  2019-01-14       Impact factor: 5.639

Review 4.  Emerging Roles of Long Non-coding RNAs in Chronic Neuropathic Pain.

Authors:  Wei Wu; Xiaojun Ji; Yang Zhao
Journal:  Front Neurosci       Date:  2019-10-18       Impact factor: 4.677

5.  Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer.

Authors:  Chun-Na Liu; Hai-Yan Zhang
Journal:  J Gene Med       Date:  2020-06-13       Impact factor: 4.565

Review 6.  The Role of Non-coding RNAs in Viral Myocarditis.

Authors:  Cong Zhang; Yan Xiong; Lijin Zeng; Zhihua Peng; Zhihao Liu; Hong Zhan; Zhen Yang
Journal:  Front Cell Infect Microbiol       Date:  2020-07-02       Impact factor: 5.293

Review 7.  Editorial focus: entering into the non-coding RNA era.

Authors:  Rafal Bartoszewski; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2018-09-18       Impact factor: 5.787

Review 8.  Editorial focus: understanding off-target effects as the key to successful RNAi therapy.

Authors:  Rafal Bartoszewski; Aleksander F Sikorski
Journal:  Cell Mol Biol Lett       Date:  2019-12-09       Impact factor: 5.787

9.  MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2.

Authors:  Zeng Weihua; Zou Guorong; Cao Xiaolong; Li Weizhan
Journal:  Cancer Cell Int       Date:  2020-03-18       Impact factor: 5.722

Review 10.  Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.

Authors:  Athina A Kyriazi; Efstathios Papiris; Konstantinos Kitsos Kalyvianakis; George Sakellaris; Stavroula Baritaki
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.